Regular follow-up with your healthcare team is essential when taking tirzepatide
Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J
Trials including SURMOUNT-1 and SURMOUNT-2 showed dose-dependent weight loss, with 15-mg doses producing approximately 20-21% body weight reduction over 72 weeks compared to 10-15% at lower doses
Common antihypertensive classesincluding ACE inhibitors, ARBs, beta-blockers, and calcium channel blockersmay need dose reductions as tirzepatide takes effect
Interestingly, an underdevelopment in this field: exploration of NAMPT inhibitors in combination with inhibitors of immune checkpoints
I really started to discover that I was really not having the same amount of pleasure or seeking the same amount of pleasure in some of the activities that I once enjoyed, Knapp, the founder of the On The Pen podcast, which focuses on GLP-1s and obesity medicine, told NBCs Anne Thompson